Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0473Source: DataRank Database

Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19 is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0. It has been cited 31 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access31 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.73)OA: bronzeTopics (80)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Carl H. June ORCID,Sangya Agarwal ORCID

Live enrichment

PubMed:32303509 PMC:PMC7249633 OpenAlex:https://openalex.org/W3016777798

NIH

Grant: 2R01CA120409

NCI NIH HHS

Grant: R01 CA120409

National Institutes of Health

Grant: 1R01CA120409-01

Immunotherapy of mesothelin expressing tumors with lentiviral engineered T cells

Parker Institute for Cancer Immunotherapy

FWCI

0.73

Citation Percentile

0.8%

Citation Trend

2020

2021

2022

2023

2024

bronzeLicense: implied-oa

journalhttps://aacrjournals.org/cancerdiscovery/article-pdf/10/6/775/1814874/775.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/10/6/775/1814874/775.pdf

journalhttps://doi.org/10.1158/2159-8290.cd-20-0473

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32303509

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7249633

Fields of Study

COVID-19 Clinical Research StudiesCAR-T cell therapy researchSARS-CoV-2 and COVID-19 Research0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsBetacoronavirusCOVID-19Calcineurin InhibitorsCell- and Tissue-Based TherapyCoronavirus InfectionsCytokinesDrug RepositioningHumansImmunotherapyInflammationLymphohistiocytosis, HemophagocyticMacrophage ActivationMorbidityNeoplasmsPandemicsPneumonia, ViralReceptors, Antigen, T-CellSARS-CoV-2

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2AnimalsHumansImmunotherapyInflammationMacrophage ActivationMorbidityNeoplasmsPneumonia, ViralReceptors, Antigen, T-CellCytokinesCoronavirus InfectionsLymphohistiocytosis, HemophagocyticDrug RepositioningPandemicsCell- and Tissue-Based TherapyCalcineurin Inhibitors

Keywords

Coronavirus disease 2019 (COVID-19)RepurposingSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakDrug repositioningImmunopathologyMedicineCytokineImmunologyBetacoronavirusT cellVirologyComputational biologyBioinformaticsBiologyImmune systemPharmacologyInternal medicineDrugInflammationSARS-CoV-2Calcineurin InhibitorsPneumonia, ViralCell- and Tissue-Based TherapyReceptors, Antigen, T-CellCOVID-19Macrophage ActivationLymphohistiocytosis, HemophagocyticNeoplasmsAnimalsCytokinesHumansImmunotherapyMorbidityCoronavirus InfectionsPandemics

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being